The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma
Open Access
- 1 January 2021
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 11 (10) , 4599-4615
Abstract
HBO1 (KAT7 or MYST2) is a histone acetyltransferase that acetylates H3 and H4 histones.Keywords
This publication has 58 references indexed in Scilit:
- JNK1 Phosphorylation of Cdt1 Inhibits Recruitment of HBO1 Histone Acetylase and Blocks Replication Licensing in Response to StressMolecular Cell, 2011
- The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicinCancer Chemotherapy and Pharmacology, 2010
- HBO1 Histone Acetylase Activity Is Essential for DNA Replication Licensing and Inhibited by GemininMolecular Cell, 2010
- Histone acetyltransferase Hbo1: Catalytic activity, cellular abundance, and links to primary cancersGene, 2009
- HBO1 HAT Complexes Target Chromatin throughout Gene Coding Regions via Multiple PHD Finger Interactions with Histone H3 TailMolecular Cell, 2009
- HBO1 histone acetylase is a coactivator of the replication licensing factor Cdt1Genes & Development, 2008
- E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemiaLeukemia, 2008
- A review of clinical and molecular prognostic factors in osteosarcomaJournal of Cancer Research and Clinical Oncology, 2007
- Current strategies of chemotherapy in osteosarcomaInternational Orthopaedics, 2006
- Translating the Histone CodeScience, 2001